Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinoblastoma Protein | 7 | 2014 | 700 | 1.630 |
Why?
|
E2F Transcription Factors | 3 | 2014 | 268 | 0.710 |
Why?
|
Genomic Instability | 3 | 2021 | 698 | 0.700 |
Why?
|
Multiple Myeloma | 7 | 2023 | 5141 | 0.590 |
Why?
|
DNA Damage | 3 | 2021 | 2467 | 0.500 |
Why?
|
Heterochromatin | 2 | 2013 | 310 | 0.490 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3777 | 0.350 |
Why?
|
G1 Phase | 1 | 2009 | 423 | 0.340 |
Why?
|
Mutation | 7 | 2021 | 29441 | 0.340 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 620 | 0.330 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1671 | 0.290 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2906 | 0.240 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 3010 | 0.230 |
Why?
|
Transcription, Genetic | 3 | 2018 | 7947 | 0.210 |
Why?
|
NM23 Nucleoside Diphosphate Kinases | 1 | 2020 | 21 | 0.210 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 1 | 2020 | 76 | 0.200 |
Why?
|
DNA Glycosylases | 1 | 2020 | 135 | 0.180 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2019 | 201 | 0.180 |
Why?
|
Chromatin | 3 | 2023 | 2730 | 0.170 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2018 | 70 | 0.170 |
Why?
|
Nuclear Proteins | 1 | 2013 | 5977 | 0.170 |
Why?
|
Gene Expression Regulation | 3 | 2014 | 12425 | 0.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2023 | 8671 | 0.160 |
Why?
|
Multiprotein Complexes | 2 | 2014 | 1172 | 0.160 |
Why?
|
BRCA2 Protein | 1 | 2022 | 699 | 0.150 |
Why?
|
Syndecan-1 | 1 | 2017 | 178 | 0.150 |
Why?
|
BRCA1 Protein | 1 | 2022 | 1046 | 0.140 |
Why?
|
DNA Replication | 2 | 2014 | 1445 | 0.140 |
Why?
|
Immobilization | 1 | 2015 | 250 | 0.130 |
Why?
|
Ubiquitin | 1 | 2019 | 864 | 0.130 |
Why?
|
E2F1 Transcription Factor | 1 | 2014 | 194 | 0.130 |
Why?
|
Transcription Factors | 1 | 2013 | 12047 | 0.120 |
Why?
|
Plasma Cells | 1 | 2017 | 601 | 0.120 |
Why?
|
Apoptosis | 3 | 2021 | 10111 | 0.120 |
Why?
|
Genes, cdc | 1 | 2012 | 126 | 0.110 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3703 | 0.110 |
Why?
|
Evolution, Molecular | 1 | 2021 | 1963 | 0.110 |
Why?
|
Cell Proliferation | 6 | 2023 | 10799 | 0.110 |
Why?
|
Cell Differentiation | 1 | 2009 | 11747 | 0.110 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1699 | 0.110 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1534 | 0.100 |
Why?
|
Aneuploidy | 1 | 2014 | 476 | 0.100 |
Why?
|
Cell Line, Tumor | 4 | 2021 | 16939 | 0.100 |
Why?
|
Signal Transduction | 3 | 2021 | 23975 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 15584 | 0.100 |
Why?
|
Hyperplasia | 1 | 2013 | 1173 | 0.100 |
Why?
|
Mice | 10 | 2023 | 80997 | 0.100 |
Why?
|
Clone Cells | 1 | 2013 | 1760 | 0.090 |
Why?
|
Adenosine Triphosphatases | 1 | 2014 | 899 | 0.090 |
Why?
|
Promoter Regions, Genetic | 2 | 2012 | 6046 | 0.090 |
Why?
|
Mammals | 1 | 2014 | 934 | 0.090 |
Why?
|
Chondrocytes | 1 | 2014 | 771 | 0.090 |
Why?
|
Fibroblasts | 4 | 2014 | 4284 | 0.090 |
Why?
|
Antibodies | 1 | 2017 | 2445 | 0.090 |
Why?
|
Protein Multimerization | 1 | 2013 | 1008 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5234 | 0.080 |
Why?
|
Radiotherapy | 1 | 2015 | 1623 | 0.080 |
Why?
|
Binding Sites | 2 | 2014 | 6289 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3458 | 0.080 |
Why?
|
Oncogenes | 1 | 2013 | 1258 | 0.080 |
Why?
|
Gene Silencing | 1 | 2013 | 1615 | 0.080 |
Why?
|
MicroRNAs | 1 | 2023 | 3673 | 0.080 |
Why?
|
Breast Neoplasms | 4 | 2022 | 20058 | 0.080 |
Why?
|
Animals | 12 | 2023 | 170733 | 0.070 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6371 | 0.070 |
Why?
|
Genomics | 1 | 2021 | 5333 | 0.070 |
Why?
|
India | 2 | 2020 | 2006 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2013 | 2970 | 0.060 |
Why?
|
Xenobiotics | 1 | 2021 | 79 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2014 | 20101 | 0.050 |
Why?
|
RNA, Catalytic | 1 | 2020 | 111 | 0.050 |
Why?
|
Humans | 17 | 2023 | 715118 | 0.050 |
Why?
|
Nucleotidyltransferases | 1 | 2021 | 206 | 0.050 |
Why?
|
Cell Line | 2 | 2014 | 16680 | 0.040 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2018 | 30 | 0.040 |
Why?
|
Glutathione Transferase | 1 | 2021 | 616 | 0.040 |
Why?
|
Neoplasms | 2 | 2019 | 20515 | 0.040 |
Why?
|
Genes, BRCA2 | 1 | 2022 | 592 | 0.040 |
Why?
|
RNA Splicing | 1 | 2023 | 878 | 0.040 |
Why?
|
Rad51 Recombinase | 1 | 2018 | 188 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2014 | 15263 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 371 | 0.040 |
Why?
|
Embryo, Mammalian | 2 | 2014 | 1764 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2023 | 1120 | 0.040 |
Why?
|
Melphalan | 1 | 2018 | 383 | 0.040 |
Why?
|
Nucleic Acid Conformation | 1 | 2020 | 958 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9785 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2020 | 1095 | 0.040 |
Why?
|
Endonucleases | 1 | 2018 | 391 | 0.030 |
Why?
|
Spectrin | 1 | 1995 | 176 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2840 | 0.030 |
Why?
|
Models, Biological | 1 | 2012 | 9893 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 971 | 0.030 |
Why?
|
Harmine | 1 | 2014 | 13 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2018 | 640 | 0.030 |
Why?
|
Lung | 1 | 2013 | 9765 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2018 | 644 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2022 | 1730 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 1996 | 1516 | 0.030 |
Why?
|
Disease Progression | 2 | 2020 | 13302 | 0.030 |
Why?
|
Centromere | 1 | 2014 | 225 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 388 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2015 | 872 | 0.030 |
Why?
|
S Phase | 1 | 2014 | 437 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6565 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3693 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2709 | 0.030 |
Why?
|
Genome | 1 | 2020 | 1750 | 0.030 |
Why?
|
Haploinsufficiency | 1 | 2014 | 312 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6676 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1995 | 2926 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2020 | 2500 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 733 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2014 | 1951 | 0.020 |
Why?
|
Blood Proteins | 1 | 1995 | 1145 | 0.020 |
Why?
|
Gene Targeting | 1 | 2014 | 907 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 6131 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2021 | 4352 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29167 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 17395 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2013 | 12566 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 1996 | 34394 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3696 | 0.020 |
Why?
|
Brain | 1 | 2015 | 25188 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2059 | 0.020 |
Why?
|
Tibia | 1 | 2014 | 1027 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2014 | 2860 | 0.020 |
Why?
|
Female | 6 | 2022 | 377328 | 0.020 |
Why?
|
Protein Conformation | 1 | 1995 | 4069 | 0.020 |
Why?
|
Models, Animal | 1 | 2014 | 2219 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3628 | 0.020 |
Why?
|
Osteogenesis | 1 | 2014 | 1289 | 0.020 |
Why?
|
Bone Marrow | 1 | 2017 | 2954 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 13255 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 1995 | 1779 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1995 | 2554 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 12921 | 0.020 |
Why?
|
Pituitary Neoplasms | 1 | 2014 | 1288 | 0.020 |
Why?
|
Cell Cycle | 1 | 2014 | 3018 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 1899 | 0.020 |
Why?
|
Models, Molecular | 1 | 1995 | 5535 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4737 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9521 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2021 | 8094 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2021 | 21789 | 0.010 |
Why?
|
Alleles | 1 | 2014 | 7095 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 14237 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9660 | 0.010 |
Why?
|
Proteins | 1 | 1996 | 6163 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 18734 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14877 | 0.010 |
Why?
|
Aged | 2 | 2020 | 162672 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19497 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 22941 | 0.010 |
Why?
|
Helix-Turn-Helix Motifs | 1 | 1995 | 13 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 51182 | 0.010 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 1995 | 121 | 0.010 |
Why?
|
Adult | 2 | 2020 | 212128 | 0.010 |
Why?
|
Middle Aged | 2 | 2020 | 214868 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58503 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 70705 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1995 | 2287 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1995 | 6858 | 0.000 |
Why?
|
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_